Discseel® Physician Application
The Discseel® Procedure provides high safety and efficacy for treating lumbar and cervical disc pathology when compared to other surgical and non-surgical treatments and is being performed more frequently by spine surgeons in the United States, Europe, and Asia.
This procedure works by utilizing FDA-approved Fibrin made by Baxter Pharmaceutical for off-label use to first seal annular tears, then stimulate disc tissue growth, permanently repairing disc pathology. A randomized, controlled study confirms the ability of Baxter’s Fibrin for off-label use to regrow disc tissue and was awarded the NASS Outstanding Paper. Safety and efficacy profiles of the Discseel® Procedure surpass all spine surgery study results.
If you believe you have the expertise to join our growing team of providers, please fill out the Discseel® physician application below and we will reach out to you if we feel you are the right fit.